Kim Woorim, Lee Sang Chul, Lee Woo-Ri, Chun Sungyoun
National Hospice Center, National Cancer Control Institute, National Cancer Center, Goyang-si, Republic of Korea; Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center, Goyang-si, Republic of Korea.
Division of Pulmonology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang-si, Republic of Korea.
Lung Cancer. 2023 Dec;186:107412. doi: 10.1016/j.lungcan.2023.107412. Epub 2023 Oct 14.
South Korea introduced the National Lung Cancer Screening Program (NLCSP) in 2019. This study investigated the effect of the NLCSP on one-year mortality in individuals with a history of lung cancer.
This study used the 2018-2020 National Health Insurance Service claims data. The difference-in-differences approach was used to investigate the effect of participating in the NLCSP between the case and control groups before and after the intervention period. The case group included individuals aged between 54 and 74 years with a smoking history of ≥ 30 pack-years and the control group those aged between 54 and 74 years with a history of smoking of <30 pack-years and non-smokers. The pre-intervention period was from January 2018 to June 2019 and the post-intervention period from July 2019 to December 2020.
The introduction of the NLCSP was related to an overall decrease in one-year mortality (-3.21 % points, 95 % Confidence Interval (CI) -4.84 to -1.58). Specifically, this reduction was significant for lung cancer related mortality (lung cancer: -2.69 % points, 95 % CI -4.24 to -1.13). Furthermore, stronger associations were found in individuals of older age, residing in non-metropolitan areas, and who visited healthcare institutions in non-metropolitan areas.
The findings confirm a relationship between implementation of the NLCSP and one-year mortality in eligible individuals with a history of lung cancer, which is noteworthy considering that Korea is one of the first countries to include lung cancer into the national cancer screening program.
韩国于2019年推出了国家肺癌筛查计划(NLCSP)。本研究调查了NLCSP对有肺癌病史个体一年死亡率的影响。
本研究使用了2018 - 2020年国家健康保险服务理赔数据。采用差异中的差异方法来调查干预期前后病例组和对照组参与NLCSP的效果。病例组包括年龄在54至74岁之间、吸烟史≥30包年的个体,对照组包括年龄在54至74岁之间、吸烟史<30包年的个体和非吸烟者。干预前期为2018年1月至2019年6月,干预后期为2019年7月至2020年12月。
NLCSP的引入与一年死亡率的总体下降相关(-3.21个百分点,95%置信区间(CI)-4.84至-1.58)。具体而言,这种下降在肺癌相关死亡率方面具有显著性(肺癌:-2.69个百分点,95%CI -4.24至-1.13)。此外,在年龄较大、居住在非大都市地区以及在非大都市地区医疗机构就诊的个体中发现了更强的关联。
研究结果证实了NLCSP的实施与有肺癌病史的符合条件个体的一年死亡率之间的关系,鉴于韩国是首批将肺癌纳入国家癌症筛查计划的国家之一,这一点值得关注。